This article talks about a company called Privia Health, which helps doctors and their practices work better. The company did not do as well as people thought it would in the last three months. They made 3 cents per share, but people expected them to make 5 cents per share. This is a surprise because usually companies try to do better than what people expect, but Privia Health did not.

This is not the first time that Privia Health has not done as well as people expected. In the last four quarters, the company has not been able to make more money than what people thought they would.

People who have shares in Privia Health are not happy because the company's shares have lost money compared to other shares. People want to know what will happen to the company and its shares in the future. One way to find out is to look at what people who work with the company think. These people are called analysts. They give their opinions on how well the company will do in the future. If they think the company will do well, they give it a higher rating, and if they think it will do poorly, they give it a lower rating.

The company's shares have a rating of "sell," which means that people think the shares will lose money in the future. This is because the company's earnings have not been as good as people thought they would be, and people who work with the company have not changed their opinions to be more positive.

People will be looking at how well Privia Health does in the next few months to see if their opinions change. If the company does well, the shares might become more valuable. If the company does not do well, the shares might lose more money. Read from source...

- The headline and the lead paragraph are misleading and do not reflect the actual earnings report of Privia Health.
- The article does not provide any analysis or insights into the company's performance, instead, it relies on external factors (Zacks Consensus Estimate, Zacks Rank, etc.) to make its point.
- The article uses outdated and irrelevant data (revenue and EPS numbers for the year ago quarter) to support its claims.
- The article does not address the reasons behind the earnings miss or the implications for the company's future prospects.
- The article ends with an unrelated and irrelevant link to another stock from the same industry.
- The article has several grammatical and punctuation errors, which undermine its credibility and readability.

{{Risk Ratings}}:
- Hold: The stock has a Zacks Rank of 4, but it has moved down to a Zacks Industry Rank of 121, which is in the bottom 43% of more than 250 Zacks industries. This suggests that the broader industry could be struggling with some key differences between the company and its peers. The stock also has a Growth Score of D, which indicates that growth is not a major focus for this company.
- Sell: The company has a negative earnings surprise of 40% for the